Jizhao Wang

1.3k total citations
31 papers, 983 citations indexed

About

Jizhao Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jizhao Wang has authored 31 papers receiving a total of 983 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Jizhao Wang's work include Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (6 papers) and Circular RNAs in diseases (5 papers). Jizhao Wang is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (6 papers) and Circular RNAs in diseases (5 papers). Jizhao Wang collaborates with scholars based in China, Mexico and Germany. Jizhao Wang's co-authors include Yuchen Sun, Jingkun Qu, Jiansheng Wang, Xixi Zhao, Xu Liu, Hangying Qu, Jia Zhang, Xingcong Ma, Shuqun Zhang and Feidi Wang and has published in prestigious journals such as ACS Nano, Biomaterials and Scientific Reports.

In The Last Decade

Jizhao Wang

30 papers receiving 977 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jizhao Wang China 16 512 340 331 317 126 31 983
Antao Chang China 19 617 1.2× 338 1.0× 390 1.2× 294 0.9× 98 0.8× 38 1.1k
Mengyu Sun China 18 489 1.0× 290 0.9× 252 0.8× 225 0.7× 183 1.5× 45 916
Guang‐Yu Lian China 14 433 0.8× 233 0.7× 247 0.7× 295 0.9× 80 0.6× 22 836
Zhenjia Yu China 12 415 0.8× 285 0.8× 362 1.1× 212 0.7× 198 1.6× 20 896
Xiaoming Dai China 19 830 1.6× 252 0.7× 320 1.0× 223 0.7× 140 1.1× 38 1.5k
Jinglei Qu China 19 611 1.2× 297 0.9× 469 1.4× 183 0.6× 213 1.7× 50 1.1k
Xiongyan Wu China 17 565 1.1× 360 1.1× 460 1.4× 276 0.9× 240 1.9× 25 1.2k
Baochi Ou China 17 602 1.2× 302 0.9× 403 1.2× 224 0.7× 118 0.9× 26 1.1k

Countries citing papers authored by Jizhao Wang

Since Specialization
Citations

This map shows the geographic impact of Jizhao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jizhao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jizhao Wang more than expected).

Fields of papers citing papers by Jizhao Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jizhao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jizhao Wang. The network helps show where Jizhao Wang may publish in the future.

Co-authorship network of co-authors of Jizhao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jizhao Wang. A scholar is included among the top collaborators of Jizhao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jizhao Wang. Jizhao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Tongyang, Jinteng Feng, Zhiyu Wang, et al.. (2025). Acid-responsive contractile hyaluronic acid-based hydrogel loaded with ginsenoside Rg1 for hemostasis and promotion of gastric wound healing. Biomaterials. 321. 123320–123320. 7 indexed citations
2.
Zhang, Guangjian, Bohao Liu, Jiaqi Huang, et al.. (2025). PROTAC-mediated structure–function disruption of CD26: a therapeutic strategy for driver-negative non-small cell lung cancer. EBioMedicine. 122. 106026–106026.
3.
Wang, Jizhao, et al.. (2024). Perception Methods for Adverse Weather Based on Vehicle Infrastructure Cooperation System: A Review. Sensors. 24(2). 374–374. 8 indexed citations
4.
Wang, Jizhao, et al.. (2024). Vehicle Trajectory Reconstruction Using Lagrange-Interpolation-Based Framework. Applied Sciences. 14(3). 1173–1173. 2 indexed citations
5.
6.
Zhang, Cheng, Xinyi Wang, Jizhao Wang, et al.. (2022). LINC-PINT suppresses cisplatin resistance in gastric cancer by inhibiting autophagy activation via epigenetic silencing of ATG5 by EZH2. Frontiers in Pharmacology. 13. 968223–968223. 18 indexed citations
7.
Sun, Yuchen, Jizhao Wang, Yuan Ma, et al.. (2021). Radiation induces NORAD expression to promote ESCC radiotherapy resistance via EEPD1/ATR/Chk1 signalling and by inhibiting pri-miR-199a1 processing and the exosomal transfer of miR-199a-5p. Journal of Experimental & Clinical Cancer Research. 40(1). 306–306. 61 indexed citations
8.
Wang, Jizhao, Yuchen Sun, Xing Zhang, et al.. (2021). Oxidative stress activates NORAD expression by H3K27ac and promotes oxaliplatin resistance in gastric cancer by enhancing autophagy flux via targeting the miR-433-3p. Cell Death and Disease. 12(1). 90–90. 60 indexed citations
9.
Zhao, Xu, Jizhao Wang, Rui Zhu, Jing Zhang, & Yunfeng Zhang. (2021). DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis. Scientific Reports. 11(1). 21014–21014. 15 indexed citations
10.
Liu, Lin, Cheng Zhang, Jizhao Wang, et al.. (2021). A high level of lncFGD5-AS1 inhibits epithelial-to-Mesenchymal transition by regulating the miR-196a-5p/SMAD6/BMP axis in gastric Cancer. BMC Cancer. 21(1). 453–453. 11 indexed citations
11.
Zhang, Cheng, et al.. (2020). <p><em>LINC00461</em> Overexpression Can Induce Docetaxel Resistance in Breast Cancer by Interacting with miR-411-5p</p>. OncoTargets and Therapy. Volume 13. 5551–5562. 15 indexed citations
12.
Sun, Yuchen, Jizhao Wang, Shupei Pan, et al.. (2018). LINC00657 played oncogenic roles in esophageal squamous cell carcinoma by targeting miR-615-3p and JunB. Biomedicine & Pharmacotherapy. 108. 316–324. 42 indexed citations
13.
Wang, Jizhao, Yuchen Sun, Jingkun Qu, et al.. (2018). Survival analysis for male ductal and lobular breast cancer patients with different stages. Future Oncology. 15(2). 167–180. 4 indexed citations
14.
Wang, Jizhao, Yuchen Sun, Jingkun Qu, et al.. (2018). miR-615-3p promotes proliferation and migration and inhibits apoptosis through its potential target CELF2 in gastric cancer. Biomedicine & Pharmacotherapy. 101. 406–413. 57 indexed citations
15.
Qu, Jingkun, Xixi Zhao, Jizhao Wang, et al.. (2018). Plasma phospholipase A2 activity may serve as a novel diagnostic biomarker for the diagnosis of breast cancer. Oncology Letters. 15(4). 5236–5242. 12 indexed citations
16.
Liu, Xu, Jingkun Qu, Jia Zhang, et al.. (2017). Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients. Medicine. 96(45). e8101–e8101. 45 indexed citations
17.
Zhang, Jing, Jiajun Lv, Yan Yan, et al.. (2017). Prognostic value of FOXQ1 in patients with malignant solid tumors: a meta-analysis. OncoTargets and Therapy. Volume 10. 1777–1781. 7 indexed citations
18.
Zhang, Jia, Yan Yan, Ya Yang, et al.. (2016). High Infiltration of Tumor-Associated Macrophages Influences Poor Prognosis in Human Gastric Cancer Patients, Associates With the Phenomenon of EMT. Medicine. 95(6). e2636–e2636. 89 indexed citations
19.
Wang, Jizhao, Yuchen Sun, Jingkun Qu, et al.. (2016). Roles of LPA receptor signaling in breast cancer. Expert Review of Molecular Diagnostics. 16(10). 1103–1111. 25 indexed citations
20.
Li, Min, Dong Xiao, Jia Zhang, et al.. (2016). Expression of LPA2 is associated with poor prognosis in human breast cancer and regulates HIF-1α expression and breast cancer cell growth. Oncology Reports. 36(6). 3479–3487. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antao Chang Breakdown of academic impact, for papers by Mengyu Sun Breakdown of academic impact, for papers by Guang‐Yu Lian Breakdown of academic impact, for papers by Zhenjia Yu Breakdown of academic impact, for papers by Xiaoming Dai Breakdown of academic impact, for papers by Jinglei Qu Breakdown of academic impact, for papers by Xiongyan Wu Breakdown of academic impact, for papers by Baochi Ou
Rankless by CCL
2026